Provided by Tiger Fintech (Singapore) Pte. Ltd.

ClearPoint Neuro, Inc.

14.70
+0.41002.87%
Pre-market: 14.800.1000+0.68%08:00 EDT
Volume:326.34K
Turnover:4.90M
Market Cap:406.20M
PE:-21.01
High:15.56
Open:14.34
Low:14.24
Close:14.29
Loading ...

Company Profile

Company Name:
ClearPoint Neuro, Inc.
Exchange:
NASDAQ
Establishment Date:
1998
Employees:
115
Office Location:
120 S. Sierra Avenue,Suite 100,Solana Beach,California,United States
Zip Code:
92075
Fax:
- -
Introduction:
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Directors

Name
Position
Francis P. Grillo
Director,Chief Executive Officer and President
Kimble L. Jenkins
Director,Chairman
Andrew K. Rooke
Director
Charles E. Koob
Director
John N. Spencer, Jr.
Director
Maria Sainz
Director
Pascal E. R. Girin
Director
Philip A. Pizzo
Director
Timothy T. Richards
Director

Shareholders

Name
Position
Francis P. Grillo
Director,Chief Executive Officer and President
Peter G. Piferi
Chief Operating Officer
Harold A. Hurwitz
Chief Financial Officer and Corporate Secretary
Robert C. Korn
Vice President, Sales
Wendelin C. Maners
Vice President, Marketing